The relationship between prescription rates of oral corticosteroids for respiratory diseases and deprivation in England

Author:

Barker ErinORCID,Pocock Jessica,Moss JoeORCID,Hex Nick,Rankin Jordan,Hudson Richard

Abstract

AbstractRespiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD), are common in England with the worst respiratory outcomes observed in the most deprived areas. There is limited published research to establish whether the rate of oral corticosteroid (OCS) prescribing for asthma and COPD is linked to levels of deprivation. This study carried out a multivariable regression analysis of publicly available data and found that deprivation is associated with a statistically significant increase in the proportion of patients receiving an OCS prescription for asthma or COPD at a GP practice level (p < 0.001). The model estimated that the proportion of prescriptions is 1.88% (95% CI 1.83% to 1.92%) and 2.84% (95% CI 2.70% to 2.98%) for the least deprived GP practice and the most deprived GP practice, respectively. This study lays the groundwork for future research using individual patient level data to consider the impact of variation in OCS prescribing rates.

Publisher

Springer Science and Business Media LLC

Reference32 articles.

1. NHS England. Respiratory Disease. https://www.england.nhs.uk/ourwork/clinical-policy/respiratory-disease/ (2022).

2. World Health Organization. Chronic Respiratory Diseases. https://www.who.int/health-topics/chronic-respiratory-diseases#tab=tab_1 (2022).

3. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. https://ginasthma.org/gina-reports/ (2022).

4. Agusti, A. et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Am. J. Resp. Crit. Care Med. 207, 819–837, https://doi.org/10.1164/rccm.202301-0106PP (2023).

5. Levy, M. et al. Why Asthma Still Kills: The National Review of Asthma Deaths (NRAD) Confidential Enquiry Report. Royal College of Physicians. https://www.rcplondon.ac.uk/projects/outputs/why-asthma-still-kills (2014).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3